| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
DexCom Inc (NASDAQ: DXCM)
DXCM Technical Analysis
5
| As on 9th Jun 2023 DXCM SHARE Price closed @ 124.34 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 260.25 & Strong Sell for SHORT-TERM with Stoploss of 450.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DXCMSHARE Price
| Open | 121.31 | Change | Price | % |
| High | 124.55 | 1 Day | 3.21 | 2.65 |
| Low | 120.20 | 1 Week | 7.08 | 6.04 |
| Close | 124.34 | 1 Month | 0.76 | 0.61 |
| Volume | 2090085 | 1 Year | -441.56 | -78.03 |
| 52 Week High 572.79 | 52 Week Low 67.99 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DXCM Daily Charts |
DXCM Intraday Charts |
Whats New @ Bazaartrend |
DXCM Free Analysis |
|
|
DXCM Important Levels Intraday
| RESISTANCE | 132.72 |
| RESISTANCE | 130.03 |
| RESISTANCE | 128.37 |
| RESISTANCE | 126.71 |
| SUPPORT | 121.97 |
| SUPPORT | 120.31 |
| SUPPORT | 118.65 |
| SUPPORT | 115.96 |
DXCM Forecast April 2024
| 4th UP Forecast | 354.39 |
| 3rd UP Forecast | 280.61 |
| 2nd UP Forecast | 235.01 |
| 1st UP Forecast | 189.4 |
| 1st DOWN Forecast | 59.28 |
| 2nd DOWN Forecast | 13.67 |
| 3rd DOWN Forecast | -31.93 |
| 4th DOWN Forecast | -105.71 |
DXCM Weekly Forecast
| 4th UP Forecast | 263.43 |
| 3rd UP Forecast | 218.82 |
| 2nd UP Forecast | 191.25 |
| 1st UP Forecast | 163.68 |
| 1st DOWN Forecast | 85.00 |
| 2nd DOWN Forecast | 57.43 |
| 3rd DOWN Forecast | 29.86 |
| 4th DOWN Forecast | -14.75 |
DXCM Forecast2024
| 4th UP Forecast | 1112.39 |
| 3rd UP Forecast | 795.52 |
| 2nd UP Forecast | 599.65 |
| 1st UP Forecast | 403.78 |
| 1st DOWN Forecast | -155.1 |
| 2nd DOWN Forecast | -350.97 |
| 3rd DOWN Forecast | -546.84 |
| 4th DOWN Forecast | -863.71 |
DexCom Inc ( NASDAQ USA Symbol : DXCM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DXCM Business Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service